Tyra Biosciences Agrees to Underwritten Offering of Common Stock and Warrants

Tyra Biosciences, Inc. has entered into an underwriting agreement with multiple firms to sell 9,079,000 shares of common stock and $9,078,529 in pre-funded warrants, subject to regulatory filing. The transaction helps the biopharmaceutical company raise capital.